hero section gradient
15 handpicked stocks

King Stallion Suppliers: Could $11B Deal Lift Stocks?

Sikorsky, a Lockheed Martin subsidiary, landed a landmark $11 billion contract to build heavy-lift helicopters for the U.S. Marine Corps. This theme focuses on the key suppliers of engines, components, and advanced materials that are essential to the helicopter's production and poised to benefit from this long-term manufacturing program.

Author avatar

Han Tan | Market Analyst

Published on September 27

Your Basket's Financial Footprint

Aggregate market cap breakdown for the basket 'King Stallion's Supply Chain Takes Flight' with investor-focused key takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and broader market-like returns; values can fall as well as rise; returns not guaranteed.
  • Suited as a core, diversified holding to anchor a portfolio; not tailored personal advice and not a speculative trade.
  • Expect steady, long-term appreciation potential rather than rapid spikes; past performance doesn't guarantee future returns.
Total Market Cap
  • LMT: $113.80B

  • SPR: $4.66B

  • HEI: $38.84B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The $11 billion CH-53K King Stallion helicopter contract represents a massive, multi-year procurement that creates sustained demand across an extensive supplier network. This long-term government spending provides revenue visibility and stability for the 267 U.S. suppliers involved in producing these advanced heavy-lift aircraft.

2

What You Need to Know

This group focuses on aerospace and defence companies that supply critical components for helicopter production - from engines and avionics to composite materials and structural parts. These are specialised manufacturers that benefit from large-scale government contracts and multi-year procurement cycles.

3

Why These Stocks

These companies were handpicked as key players in the King Stallion supply chain, positioned to receive steady orders for years to come. Professional analysts identified these firms as having significant exposure to the helicopter programme and the broader aerospace defence sector.

Why You'll Want to Watch These Stocks

🚁

Multi-Year Revenue Stream

The $11 billion contract spans multiple years, providing sustained demand and revenue visibility for suppliers throughout the production cycle.

🎯

Government Spending Momentum

This massive procurement signals continued strong investment in military aviation, potentially setting the stage for additional defence contracts.

⚙️

Supply Chain Ripple Effect

With 267 U.S. suppliers involved, this programme creates a significant multiplier effect across the aerospace and defence industry.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.

Cargo Capacity Crisis: Which Stocks May Benefit Most?

Cargo Capacity Crisis: Which Stocks May Benefit Most?

The crash of a UPS cargo plane has led to the grounding of an entire class of aging aircraft across the logistics industry. This creates a potential investment opportunity in competing cargo carriers and aircraft manufacturers poised to fill the resulting gap in shipping capacity.

UK-US Pharma Trade Deal | Tariff-Free Market Access

UK-US Pharma Trade Deal | Tariff-Free Market Access

A new trade deal eliminates tariffs on pharmaceuticals between the UK and the US, strengthening transatlantic trade. This creates a powerful tailwind for pharmaceutical companies in both countries, potentially boosting exports, innovation, and profitability.

Frequently Asked Questions